Purpose: To prospectively evaluate contrast material–enhanced ultrasonography (US) with
microbubbles targeted to vascular endothelial growth factor receptor type 2 (VEGFR2) for …

Purpose To develop and validate a dual-targeted ultrasonographic (US) imaging agent with
microbubbles (MBs) that attaches to both vascular endothelial growth factor (VEGF) receptor …

Purpose We performed a first-in-human clinical trial on ultrasound molecular imaging (USMI)
in patients with breast and ovarian lesions using a clinical-grade contrast agent (kinase …

Beyond the emerging field of oncological ultrasound molecular imaging, the recent significant
advancements in ultrasound and contrast agent technology have paved the way for …

Purpose: To evaluate in vivo whole-body biodistribution of microbubbles (MBs) targeted to
tumor angiogenesis–related vascular endothelial growth factor (VEGF) receptor 2 (VEGFR2) …

Targeted contrast-enhanced ultrasound imaging is increasingly being recognized as a powerful
imaging tool for the detection and quantification of tumor angiogenesis at the molecular …

Ovarian cancer is the most lethal of the gynecologic malignancies. Because ovarian cancer
symptoms are subtle and nonspecific, the diagnosis is often delayed until the disease is well …

Ultrasound complements mammography as an imaging modality for breast cancer detection,
especially in patients with dense breast tissue, but its utility is limited by low diagnostic …

Background Increasing efforts and financial resources are being invested in early cancer
detection research. Blood assays detecting tumor biomarkers promise noninvasive and …

Differentiation between posttherapy radiation necrosis and recurrent tumor in humans with
brain tumor is still a difficult diagnostic task. The new PET tracers 18 F-fluoro-ethyl-l-tyrosine (…